|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02666 UNI MEDICAL
Nominal 
6.290 -0.110 (-1.719%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 7,580,699 | 15.865% | 6,542,690 | 6,739,100 | 5,712,259 | 5,007,536 |
| Cost of Sales | (4,977,637) | 16.331% | (4,278,866) | (4,466,133) | (3,331,598) | (2,643,912) |
| Gross Profit | 2,603,062 | 14.985% | 2,263,824 | 2,272,967 | 2,380,661 | 2,363,624 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (48,492) | -55.546% | (109,083) | (94,934) | (137,588) | (171,730) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | (613) | (93) | (17) | -- | |
| Share of Results of Asso. & JCEs | (904) | -- | 13,636 | 5,214 | 5,840 | 7,134 | |
| Profit / (Loss) before Taxation | 1,741,315 | 7.577% | 1,618,674 | 1,564,475 | 1,504,802 | 1,475,514 | |
| Taxation | (406,088) | 10.801% | (366,501) | (369,721) | (328,442) | (349,991) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (76,421) | -3.520% | (79,209) | (54,901) | (51,167) | (39,967) | |
| Others | (30,673) | -14.151% | (35,729) | (42,793) | (35,828) | (35,600) | |
| Profit / (Loss) Attributable to Shareholders | 1,228,133 | 7.993% | 1,137,235 | 1,097,060 | 1,089,365 | 1,049,956 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 17,327 | -- | (6,014) | (34,288) | (23,108) | (7,917) |
| Depreciation & Amortisation | 342,648 | 30.750% | 262,063 | 244,826 | 196,609 | 155,988 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 65.000 | 8.333% | 60.000 | 58.000 | 58.000 | 57.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 9.337 | -- | 8.940 | 7.738 | 6.987 | 6.496 |
| Remarks: | Real time quote last updated: 22/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,228,133 |
| %Change | 7.993% |
| EPS / (LPS) | RMB 0.650 |
| NBV Per Share (¥) | RMB 9.337 |